Quoin Pharmaceuticals (QNRX) to Release Earnings on Thursday

Quoin Pharmaceuticals (NASDAQ:QNRX) is scheduled to be announcing its earnings results before the market opens on Thursday, August 8th. Analysts expect the company to announce earnings of ($0.75) per share for the quarter.

Quoin Pharmaceuticals (NASDAQ:QNRX) last released its quarterly earnings data on Thursday, May 9th. The company reported ($1.11) EPS for the quarter. On average, analysts expect Quoin Pharmaceuticals to post $-4 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Quoin Pharmaceuticals Stock Up 1.8 %

Shares of NASDAQ:QNRX traded up $0.01 on Tuesday, reaching $0.57. 22,121 shares of the company’s stock were exchanged, compared to its average volume of 282,070. The business’s 50-day moving average is $0.65 and its two-hundred day moving average is $1.33. Quoin Pharmaceuticals has a fifty-two week low of $0.52 and a fifty-two week high of $6.76. The firm has a market capitalization of $2.27 million, a price-to-earnings ratio of -0.08 and a beta of 1.96.

About Quoin Pharmaceuticals

Quoin Pharmaceuticals, Ltd., a clinical stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases. Its lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). The company is also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat NS; and QRX008 for the treatment of scleroderma.